Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation
- 22 June 2011
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 6 (8) , 1371-1389
Abstract
A hit optimization protocol applied to the first nonnucleoside inhibitor of the ATPase activity of human DEAD‐box RNA helicase DDX3 led to the design and synthesis of second‐generation rhodanine derivatives with better inhibitory activity toward cellular DDX3 and HIV‐1 replication. Additional DDX3 inhibitors were identified among triazine compounds. Biological data were rationalized in terms of structure–activity relationships and docking simulations. Antiviral activity and cytotoxicity of selected DDX3 inhibitors are reported and discussed. A thorough analysis confirmed human DDX3 as a valid anti‐HIV target. The compounds described herein represent a significant advance in the pursuit of novel drugs that target HIV‐1 host cofactors.Keywords
This publication has 30 references indexed in Scilit:
- Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulationBiochemical Pharmacology, 2010
- Genome-Scale RNAi Screen for Host Factors Required for HIV ReplicationCell Host & Microbe, 2008
- Pharmacophore Modeling and Molecular Docking Led to the Discovery of Inhibitors of Human Immunodeficiency Virus-1 Replication Targeting the Human Cellular Aspartic Acid−Glutamic Acid−Alanine−Aspartic Acid Box Polypeptide 3Journal of Medicinal Chemistry, 2008
- Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 ReplicationCell, 2008
- Knockdown of Cellular RNA Helicase DDX3 by Short Hairpin RNAs Suppresses HIV-1 Viral Replication Without Inducing ApoptosisMolecular Biotechnology, 2008
- DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA ReplicationJournal of Virology, 2007
- The DDX3 Subfamily of the DEAD Box Helicases: Divergent Roles as Unveiled by Studying Different Organisms and In Vitro AssaysCurrent Medicinal Chemistry, 2007
- Viral and cellular RNA helicases as antiviral targetsNature Reviews Drug Discovery, 2005
- Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export FunctionCell, 2004
- Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics*Annals of Internal Medicine, 2001